Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education
NCT ID: NCT02907151
Last Updated: 2018-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2016-09-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department
NCT03645564
Compliance With The European Society Of Cardiology Prevention Guidelines In Patients at High Cardiovascular Disease Risk
NCT03483155
Study of the Efficiency of Education About Cardiovascular Risk Factors in Patients After an Acute Coronary Syndrome
NCT00337480
Platform Therapeutic Education in Heart Failure and Coronary Disease
NCT01869452
Effectiveness of a Website and Telemonitoring in Patients With Heart Failure.
NCT01755988
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The assumption is that this questionnaire would help educate patients about their shortcomings and educate cardiologists lack of knowledge of his patient.
The secondary objectives are :
* Target specific areas in which patients have the greatest lack of information
* Assess the impact of educational level on information
* Assess the impact of age on information
* Evaluate the satisfaction of the information delivered
* Assess patient anxiety vis-à-vis their treatment
* Evaluate the failure rate of the questionnaire to know the number of patients refusing to participate in the study
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pre-consultation survey group
The group completing a pre consultation survey filled the same questionnaire in post consultation but the doctor will see the result in the consultation.
Survey
Complete a survey prior to the consultation and a questionnaire after
Group absence of pre-consultation survey
This group will be a control group to see if there is a difference between completing a pre-consultation survey before or not.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Complete a survey prior to the consultation and a questionnaire after
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients on oral anticoagulant therapy (warfarin or AOD) for over a month.
Exclusion Criteria
* Disorders of the important vision.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florence Leclercq, MD PHD
Role: STUDY_DIRECTOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leclercq
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL16_0275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.